- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05963477
Pediatric Post-operative Abdominal Wound Dehiscence in Association With Midline vs Other Incisions: A Prospective Cohort Study
July 19, 2023 updated by: Abdullah Bahloli, French Medical Institute for Mothers and Children
Pediatric Post-operative Abdominal Wound Dehiscence in Association With Midline vs Other Incisions in Tertiary Care Setting Kabul Afghanistan: A Cohort Study
This study is designed to see different abdominal incisions complication among neonates, infants and children and to find risk factors for developing wound dehiscence
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
270
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kabul, Afghanistan, 1006
- French Medical Institute for Mothers and Children
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
all patients from neonatal age until 18 years old who were planned to undergo abdominal surgery.
Description
Inclusion Criteria:
-all abdominal surgeries patient under 18-year-old.
Exclusion Criteria:
- Umbilical hernia, redo laparatomy, laparoscopic surgery.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Age Group
Neonates Infants Children
|
all abdominal procedures which are approached by different incisions
|
|
Gender
Male Female
|
all abdominal procedures which are approached by different incisions
|
|
Selective/Emergency
Selective Emergency
|
all abdominal procedures which are approached by different incisions
|
|
Wound Class
Clean Clean-contaminated Contaminated Infected
|
all abdominal procedures which are approached by different incisions
|
|
Risk Factors
Yes No
|
all abdominal procedures which are approached by different incisions
|
|
Type of Incisions
Midline Trransverse Oblique
|
all abdominal procedures which are approached by different incisions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wound dehiscence or burst abdomen
Time Frame: one month after intervention
|
the overall outcome of the intervention (incisions) is wound dehiscence in different age groups, in gender, among who has or has no risk factors and among different wound class
|
one month after intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2018
Primary Completion (Actual)
June 30, 2020
Study Completion (Actual)
June 30, 2020
Study Registration Dates
First Submitted
July 19, 2023
First Submitted That Met QC Criteria
July 19, 2023
First Posted (Actual)
July 27, 2023
Study Record Updates
Last Update Posted (Actual)
July 27, 2023
Last Update Submitted That Met QC Criteria
July 19, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 40-FMIC-ER-18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wound Dehiscence
-
St. Borbala HospitalSemmelweis University; Department of Surgery, Jahn Ferend Dél-Pesti Kórház... and other collaboratorsTerminatedSurgical Wound | Surgical Site Infection | Wound Dehiscence, Surgical | Dehiscence of Internal Surgical WoundHungary
-
Ilker UckayActive, not recruitingWound | Wound DehiscenceSwitzerland
-
RedDress Ltd.RecruitingDehiscence WoundIsrael
-
SeraffixTerminatedDehiscence, Surgical WoundIsrael
-
University of Southern California3MWithdrawnWound Heal | Wound Dehiscence
-
SeraffixCompletedDehiscence, Surgical WoundIsrael
-
Indus Hospital and Health NetworkCompletedWound Closure After Total Knee Arthroplasty: Comparison of Polypropylene and Polyglactin 910 Suture.Wound Heal | Wound Complication | Wound DehiscencePakistan
-
Kocaeli UniversityCompletedCesarean Section; Dehiscence | Cesarean Wound; DehiscenceTurkey
-
King Edward Medical UniversityMayo Hospital LahoreRecruiting
-
Stockholm South General HospitalUnknownWound; Perineal Rupture, DehiscenceSweden